Caesars Entertainment, Inc. research snapshot
CZR AI stock analysis reads Caesars Entertainment as a stock in a pending all-cash acquisition rather than a normal operating equity. On May 28, 2026 Caesars signed a definitive agreement to be taken private by Fertitta Entertainment for $31.00 per share in cash, a transaction valued at about $17.6 billion including roughly $11.9 billion of assumed debt. At the August 3, 2026 data cutoff CZR traded near $29.78, about 4% below the deal price, a spread that reflects up to 10 months of regulatory and shareholder approval risk. The business itself is stable: TTM revenue of $11.65 billion, Q2 2026 adjusted EBITDA of $920 million, and company-reported net debt of $10.84 billion as of June 30, 2026. Upside is capped near the deal price unless a competing bid emerges, while a failed deal could pull the stock toward the $24 to $27 standalone range. This is informational research and not investment advice.
Current price
$29.78
Market cap
About $6.06 billion
AI score
59 / 100
Rating
Merger arbitrage, hold, upside capped near the $31.00 deal price
Trend status
Uptrend into the 52-week high, trading about 4% below the $31.00 acquisition price
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Caesars operates more than 50 casino resorts across 18 states plus digital sports betting and iGaming in 42 jurisdictions. Q2 2026 revenue rose 3.0% to $2.99 billion on strong regional results, while Las Vegas revenue fell 3.5%. The business generates steady cash flow but is structurally GAAP-unprofitable because of roughly $2.3 billion of annual interest expense. | High |
| Moat | State-regulated gaming licenses, the Caesars Rewards loyalty program with more than 60 million members, a portfolio of brands including Caesars Palace and Harrahs, and a property base supported by VICI and GLPI lease structures create meaningful barriers to new competition in each regional market. | Medium-high |
| Management | CEO Tom Reeg led the Eldorado-Caesars combination and delivered the promised cost synergies. Since the Fertitta agreement was signed, management has suspended guidance and skipped the Q2 earnings call, consistent with a take-private process now being managed primarily for regulatory approval and deal closure. | Medium |
| Financial trend | TTM revenue of $11.65 billion is stable with modest growth. Q2 2026 adjusted EBITDA of $920 million was down 3.7% from a year earlier, with Las Vegas EBITDA down 12.6% and regional EBITDA up 11.2%. Total debt was $11.8 billion and net debt $10.84 billion at June 30, 2026, with $965 million of cash on hand. | High |
| Valuation | At $29.78 the stock trades about 4% below the $31.00 signed all-cash deal price. Yahoo lists an EV/EBITDA of about 9.2x on a lease-adjusted enterprise value near $29.9 billion and a price-to-sales ratio of 0.52x. The $31.00 deal price, not fundamental multiples, is the binding valuation anchor. | Medium |
| Technical trend | CZR is up 27% year to date and trades near the 52-week high of $30.88, above the 50-day moving average of $29.59 and the 200-day moving average of $25.41. RSI near 50.7 is neutral. Volume is below average, and the $31.00 deal price acts as a technical cap. | Medium |
| Risk level | Medium-high. The dominant risk is binary: the Fertitta deal may fail, be delayed beyond 10 months, or be repriced lower. Balance-sheet debt of $11.8 billion and large off-balance-sheet lease obligations to VICI and GLPI add leverage risk, and a consumer recession would pressure discretionary gaming spend. Beta is high at 1.76. | Medium-high |
| AI confidence | High for confirmed deal terms, quarterly financials, balance sheet, and analyst data. Lower for the deal outcome and any price above $31.00, because the completion probability and regulatory timing depend on decisions outside public data. | Medium-high data confidence |
| Investment certainty | Medium. The $31.00 cash consideration is a defined anchor that caps upside and defines a cleaner downside if the deal closes. If the deal fails, equity reverts to a standalone value below the current price, so the risk-reward is asymmetric and driven by deal probability. | Medium |
CZR AI stock forecast
The CZR AI stock forecast is a merger arbitrage scenario, not a fundamental earnings forecast. With a signed $31.00 per share all-cash offer from Fertitta Entertainment announced on May 28, 2026, the price is unlikely to move far above the deal price unless a competing bid appears. The realistic range runs from deal-completion near $31.00 down to a standalone value near $24 to $27 if the deal fails. These are scenario outputs, not promised targets.
$31.00 to $33.00
More likely if the Fertitta deal closes as signed, if shareholder and gaming regulatory approvals advance on schedule, or if a competing bidder emerges and pushes the consideration above $31.00. Any gain beyond the deal price requires a new offer that has not been announced.
$29.75 to $31.00
More likely if the deal progresses through up to 10 months of regulatory review without major setbacks, the spread narrows as approvals clear, and the stock converges toward the $31.00 cash consideration. Most of the 19 analyst price targets cluster near $31.00, the deal price.
$24.00 to $27.00
More likely if the Fertitta deal collapses or is repriced lower, if antitrust or gaming regulators reject the combination, if financing falls through, or if a consumer recession hits gaming revenue while the company still carries $11.8 billion of debt. Argus carries a $24.00 sell-side target that represents this standalone downside.
CZR AI technical analysis
CZR AI technical analysis reflects a stock in a steady uptrend that has pushed near its 52-week high, but the technical picture is now governed by the $31.00 Fertitta deal price. As of the August 3, 2026 cutoff, CZR closed at $29.78, up 27% year to date and above its 50-day and 200-day moving averages. RSI near 50.7 is neutral, volume is below average, and the $30.88 to $31.00 zone is the key resistance that also matches the acquisition price. The 200-day moving average near $25.41 is the main trend-invalidation level.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $29.78 | Closing price on August 3, 2026, the quote snapshot for this page. Data cutoff August 3, 2026. |
| Near support | $29.00 to $29.50 | Recent intraday consolidation zone. A pullback into this area would be normal while the stock waits for deal news. |
| 200-day moving average support | $25.41 | The 200-day moving average computed from daily closes. CZR trades well above it, confirming the intermediate-term uptrend. |
| Near resistance | $30.88 to $31.00 | The 52-week intraday high of $30.88 and the $31.00 Fertitta deal price form a tight resistance band. The deal price acts as a hard ceiling for any normal trading advance. |
| 50-day moving average | $29.59 | The 50-day moving average. CZR sits just above it, consistent with a modestly positive short-term trend. |
| Momentum | RSI about 50.7 | Neutral momentum. CZR is neither overbought nor oversold, and the RSI gives little directional edge while the stock waits on the deal. |
| Volume | Well below the 5.6 million 3-month average | Trading volume has declined, typical of a merger arbitrage situation where shares trade on deal headlines rather than fundamentals. Watch for volume on any break of the $30.88 to $31.00 band. |
| Volatility | High (beta 1.76) | CZR is nearly twice as volatile as the market, and the binary deal outcome adds event risk that normal volatility models do not capture. |
| Invalidation | Close below $25.41 | A decisive close below the 200-day moving average would break the uptrend and signal that the market is pricing a failed or repriced deal, not a normal pullback. |
CZR AI trading strategy
The CZR AI trading strategy is a risk-control framework built around a pending merger, not personalized advice. Because the $31.00 Fertitta deal price caps upside and the main risk is deal failure, position sizing and event monitoring matter more than entry timing. Anyone trading CZR should track regulatory filings, shareholder votes, and deal deadlines alongside the usual price levels.
The deal trades at roughly 4% below the $31.00 cash consideration as of the August 3, 2026 cutoff. The position captures the spread if the deal closes after the expected regulatory process, which Caesars says could take up to 10 months. Annualized, that is a modest return for taking binary completion risk.
The trade loses if the deal fails or is repriced. Monitor shareholder approval, state gaming and federal regulatory milestones, financing conditions, and the going-private timing. Cap exposure because a deal break can gap the stock toward the $24 to $27 standalone range.
While CZR stays above the 50-day moving average near $29.59, the uptrend is intact. A volume-confirmed move through the $30.88 to $31.00 band would signal the market believes the deal is advancing, but the upside above the deal price is limited without a competing bid.
A close back below the 50-day moving average, or a close below the 200-day moving average near $25.41, would invalidate the setup. Given the 1.76 beta, use stops that allow for normal intraday noise while respecting the $31.00 cap.
Track the Fertitta deal timeline, regulatory and antitrust filings, the shareholder vote, Q3 2026 results in October 2026, Las Vegas and regional revenue trends, Caesars Digital EBITDA, and the spread between the stock and the $31.00 consideration.
A widening spread signals rising deal doubt; a collapse in the deal could gap the stock toward the $24 to $27 range. Weigh the asymmetry of a capped $1.20 gain against a possible $3 to $5 loss before sizing the position.
Investment research summary
Caesars operates casino resorts where customers gamble, dine, stay overnight, and attend shows, and it runs online sports betting and iGaming. The company collects a share of every wager and charges for rooms, food, and entertainment across more than 50 properties in 18 states.
State-regulated gaming licenses limit competition in each market. Caesars Rewards creates switching costs for frequent players, and the brand portfolio of Caesars Palace, Harrahs, Horseshoe, and Eldorado spans premium and value segments. The property base is supported by long-term lease arrangements with VICI and GLPI.
The thesis fails if the Fertitta deal collapses or is repriced, if regulators reject the combination, if financing falls through, or if a consumer recession cuts gaming revenue while the company carries $11.8 billion of debt and large off-balance-sheet lease obligations. In any of those cases the equity would likely retest the $24 to $27 standalone range.
Tom Reeg has led Caesars since before the Eldorado merger and delivered the promised cost synergies. Since the Fertitta agreement was signed, management suspended guidance and skipped the Q2 earnings call, so the test now is how cleanly the company and its advisors execute the regulatory and shareholder approval process.
US gaming is a mature but resilient industry. Regional markets are benefiting from limited new supply and steady demand, with regional adjusted EBITDA up 11.2% in Q2 2026. Las Vegas is softening, and online sports betting and iGaming remain competitive and capital-intensive. The sector is cyclical and sensitive to consumer spending.
The $31.00 all-cash deal price is the clearest valuation anchor and the margin of safety is the roughly 4% spread at the current $29.78 quote. On a standalone basis the stock trades near 9.2x lease-adjusted EV/EBITDA and 0.52x sales, but the discount to the deal price mainly reflects completion risk over a process that could take up to 10 months.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| CZR price | $29.78 | Yahoo Finance and Google Finance | August 3, 2026 |
| Market capitalization | About $6.06 billion, calculated from $29.78 x 203.72 million shares, verified with 0.11% deviation vs Yahoo | Yahoo Finance and Google Finance, verified via financial_rigor.py | August 3, 2026 |
| Shares outstanding | 203.72 million common shares | Google Finance, consistent with the 204 million weighted average in Q2 2026 filings | August 3, 2026 |
| Enterprise value | About $29.92 billion, lease-adjusted | Yahoo Finance statistics, as of July 30, 2026 | August 3, 2026 |
| TTM revenue | $11.65 billion, cross-validated at 0.00% deviation across sources | Google Finance quarterly income statements and Yahoo Finance | August 3, 2026 |
| Q2 2026 revenue | $2.99 billion, up 3.0% year over year | Caesars Q2 2026 press release, July 28, 2026 | July 28, 2026 |
| Q2 2026 adjusted EBITDA | $920 million, down 3.7% from $955 million a year earlier | Caesars Q2 2026 press release, July 28, 2026 | July 28, 2026 |
| Q2 2026 net loss and EPS | GAAP net loss of $62 million, diluted EPS of -$0.30 | Caesars Q2 2026 press release, July 28, 2026 | July 28, 2026 |
| TTM diluted EPS | -$2.27 | Yahoo Finance and Google Finance | August 3, 2026 |
| Total debt and net debt | Total debt $11.81 billion, net debt $10.84 billion, cash $965 million | Caesars Q2 2026 press release balance sheet, June 30, 2026 | July 28, 2026 |
| TTM levered free cash flow | $762.5 million | Yahoo Finance cash flow statistics | August 3, 2026 |
| Fertitta acquisition terms | $31.00 per share in cash, about $17.6 billion total value including roughly $11.9 billion of assumed debt | Caesars press release, announced May 28, 2026 | May 28, 2026 |
| Analyst consensus | Hold, average 12-month target $30.71 (MarketBeat, 19 ratings) and $31.00 (Google Finance, 14 ratings) | MarketBeat and Google Finance analyst ratings | August 3, 2026 |
| Short interest | 18.58 million shares, 9.23% of float, 4.4 days to cover | MarketBeat short interest, record date July 15, 2026 | August 3, 2026 |
| Technical snapshot | 52-week range $17.86 to $30.88, RSI about 50.7, beta 1.76, 200-day moving average $25.41 | Yahoo Finance and Yahoo chart data, computed via financial_rigor.py | August 3, 2026 |
This CZR AI stock analysis page is an informational research tool only. It is not investment advice, tax advice, a recommendation, or a promise of future returns. Forecast ranges are scenarios based on public filings, the Fertitta acquisition agreement, quote snapshots, technical data, and third-party sources as of August 3, 2026. They may be wrong, incomplete, or outdated after regulatory decisions, the shareholder vote, deal termination, new earnings, debt changes, market moves, or macro conditions. The pending acquisition may fail or be repriced, and this page should not be treated as a prediction of that outcome.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
